The effect of sub-epidermal moisture on pressure injury prevention strategies and incidence of pressure injuries: A feasibility pilot randomised controlled trial.
Localised oedema
Pressure injury
Pressure ulcer
SEM
Sub-epidermal moisture
Visual skin assessment
Journal
Journal of tissue viability
ISSN: 0965-206X
Titre abrégé: J Tissue Viability
Pays: England
ID NLM: 9306822
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
18
04
2022
revised:
20
07
2022
accepted:
21
07
2022
pubmed:
8
8
2022
medline:
21
12
2022
entrez:
7
8
2022
Statut:
ppublish
Résumé
Sub-epidermal moisture scanning (SEMS) is a novel point-of-care technology that measures localised oedema and detects early tissue damage that may develop into a pressure injury (PI). It provides objective data that may assist PI prevention (PIP) decision making. This study aimed to determine the feasibility of undertaking a definitive randomised controlled trial (RCT) to test the effectiveness of SEMS. This pilot RCT recruited medical and surgical patients at risk of developing a PI in one Australian hospital. All participants received routine PIP care and daily visual skin assessment to determine the presence of a PI. The intervention group also received daily SEMS. Clinical staff were told if the sub-epidermal moisture (SEM) value was abnormal but were not given advice for PIP. Blinding of patients, care staff and outcome assessors was not practical. Feasibility outcomes included recruitment, retention, intervention fidelity, and patient outcomes. Of 1185 patients screened prior to eligibility, 950 were excluded (80%); 235 were then assessed for eligibility and 160 met the inclusion criteria (68.1%); 100 were recruited (70.0%) and randomised and 99 completed the trial (intervention n = 50; control n = 49) with one person withdrawn due to inappropriate recruitment (100% retention). Of the 657 expected SEMS observations, 598 were completed (91% intervention fidelity). Only 34 of 454 (7.4%) patient outcome data points were missing. Most feasibility criteria were met, indicating a definitive trial to assess the effectiveness of SEMS in a medical-surgical patient population is realistic. However, recruitment may be resource intensive and require specific strategies.
Identifiants
pubmed: 35934637
pii: S0965-206X(22)00082-1
doi: 10.1016/j.jtv.2022.07.008
pii:
doi:
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Pagination
776-782Informations de copyright
Copyright © 2022 Tissue Viability Society / Society of Tissue Viability. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Jill Campbell reports a relationship with Hartmann Pty Ltd that includes: consulting or advisory. Zena Moore reports a relationship with BBI Global Scientific Advisory Board that includes: board membership and consulting or advisory. Gary Allen reports a relationship with Australasian Human Research Ethics Consultancy Services that includes: employment. Fiona Coyer reports a relationship with Molnlycke Pty Ltd that includes: consulting or advisory. School of Nursing & Midwifery, RCSI, has a research collaboration with BBI.